Related Experiment Video
Updated: May 14, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Hypertension, coronary heart disease and stroke: should the blood pressure J-curve be a concern?]
1Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. jnogueira@fm.ul.pt
Insights
The J-curve phenomenon shows that lowering blood pressure too much can paradoxically increase cardiovascular events in some patients. This suggests a cautious, individualized treatment approach is needed, especially for those with coronary artery disease.
Area of Science:
- Cardiology
- Hypertension Management
- Clinical Outcomes Research
Context:
- The J-curve describes a paradoxical increase in cardiovascular events with treatment-induced low blood pressure (BP), particularly in hypertensive patients with coronary artery disease (CAD).
- This phenomenon contradicts some observational studies and remains controversial despite recent clinical trials.
- The diastolic J-curve is often more pronounced than the systolic J-curve.
Purpose:
- To review the evidence for the J-curve phenomenon in cardiovascular disease.
- To explore the reasons for the J-curve's impact on coronary artery disease versus stroke.
- To provide evidence-based recommendations for BP management in high-risk patients.
Summary:
- Recent large trials and meta-analyses support the existence of J-curves for both systolic and diastolic BP, with diastolic BP often showing a more significant effect.
- Unlike cardiovascular events, stroke risk did not consistently follow a J-curve pattern, likely due to differences in autoregulation and coronary perfusion occurring during diastole.
- The review suggests avoiding systolic BP below 120-125 mmHg and diastolic BP below 70-75 mmHg in hypertensive patients with CAD or high risk for impaired coronary blood flow.
Impact:
- Highlights the importance of individualized BP targets in hypertensive patients with CAD.
- Recommends specific BP thresholds to mitigate the risk of cardiovascular events associated with overly aggressive BP lowering.
- Informs clinical practice guidelines for managing hypertension in patients with established or high-risk coronary artery disease.
Abstract:
The paradoxical increase in cardiovascular events in patients with treatment-induced low blood pressure (BP), particularly in hypertensives with pre-existing coronary artery disease, especially those with critically low diastolic BP, which conflicts with data from epidemiologic observational studies, is referred to as a J-curve. It was first described over 30 years ago and is still the subject of considerable controversy. Recent large clinical outcomes trials (INVEST, TNT, ONTARGET, PROVE IT-TIMI 22, SMART) and meta-analyses strongly support its existence for systolic and diastolic BP. The diastolic J-curve is commonly more pronounced. In contrast to cardiovascular complications related to coronary artery disease, no J-curve phenomenon was noted for stroke in most of these studies. This is explained by differences in cerebral and coronary autoregulation and because coronary perfusion occurs only during diastole. On the basis of this review, we suggest a cautious, individualized approach to treatment, particularly in hypertensive patients with coronary heart disease or high risk for impaired coronary blood flow. In these patients we advise against treatment that lowers systolic BP below 120-125 mmHg and, particularly, diastolic BP below 70-75 mmHg.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
